Cargando…

Emerging Roles of SKP2 in Cancer Drug Resistance

More than half of all cancer patients receive chemotherapy, however, some of them easily acquire drug resistance. Resistance to chemotherapy has become a massive obstacle to achieve high rates of pathological complete response during cancer therapy. S-phase kinase-associated protein 2 (Skp2), as an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Ting, Gu, Xinsheng, Cui, Hongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150781/ https://www.ncbi.nlm.nih.gov/pubmed/34068643 http://dx.doi.org/10.3390/cells10051147

Ejemplares similares

Insights into the critical role of the PXR in preventing carcinogenesis and chemotherapeutic drug resistance
por: Niu, Xiaxia, et al.
Publicado: (2022)

Regulation of Skp2 Expression and Activity and Its Role in Cancer Progression
por: Chan, Chia-Hsin, et al.
Publicado: (2010)

Roles of the Skp2/p27 axis in the progression of chronic nephropathy
por: Suzuki, Sayuri, et al.
Publicado: (2012)

Skp2 and Its Emerging Role in the Pathogenesis of Systemic Malignancies Besides Breast Carcinomas
por: Kapoor, Shailendra
Publicado: (2012)

Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis
por: Wang, Guocan, et al.
Publicado: (2012)

USP2 is an SKP2 deubiquitylase that stabilizes both SKP2 and its substrates
por: Zhang, Fengwu, et al.
Publicado: (2021)

Skp2 and Skp2B team up against Rb and p53
por: Germain, Doris
Publicado: (2011)

Drosophila Skp1 Homologue SkpA Plays a Neuroprotective Role in Adult Brain
por: Dabool, Lital, et al.
Publicado: (2020)

Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells
por: Yang, Q, et al.
Publicado: (2014)

MYC Modulation around the CDK2/p27/SKP2 Axis
por: Hydbring, Per, et al.
Publicado: (2017)

USP10 modulates the SKP2/Bcr-Abl axis via stabilizing SKP2 in chronic myeloid leukemia
por: Liao, Yuning, et al.
Publicado: (2019)

Skp2 is a Promising Therapeutic Target in Breast Cancer
por: Wang, Zhiwei, et al.
Publicado: (2012)

Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel
por: Huang, Tonghai, et al.
Publicado: (2017)

Skp2 modulates proliferation, senescence and tumorigenesis of glioma
por: Wu, Juan, et al.
Publicado: (2020)

Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer
por: Davidovich, Shirly, et al.
Publicado: (2008)

Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer
por: Rezaeian, Abdol-Hossein, et al.
Publicado: (2023)

Skp2: A dream target in the coming age of cancer therapy
por: Chan, Chia-Hsin, et al.
Publicado: (2014)

Dioscin: A new potential inhibitor of Skp2 for cancer therapy
por: Jiang, Wenxiao, et al.
Publicado: (2020)

Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer
por: Yu, Xinfang, et al.
Publicado: (2022)

Nuclear Receptor PXR Confers Irradiation Resistance by Promoting DNA Damage Response Through Stabilization of ATF3
por: Niu, Xiaxia, et al.
Publicado: (2022)

The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth
por: Tsai, Yuh-Shyan, et al.
Publicado: (2014)

Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer
por: Riquelme, Ismael, et al.
Publicado: (2016)

The Amelioration of Renal Damage in Skp2-Deficient Mice Canceled by p27 (Kip1) Deficiency in Skp2(−/−) p27(−/−) Mice
por: Suzuki, Sayuri, et al.
Publicado: (2012)

Cryo-EM structure of SKP1-SKP2-CKS1 in complex with CDK2-cyclin A-p27KIP1
por: Rowland, Rhianna J., et al.
Publicado: (2023)

Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells
por: Liu, Yanling, et al.
Publicado: (2020)

The Conserved Function of Skp1 in Meiosis
por: McLoud, Josh D., et al.
Publicado: (2012)

Role of the F-Box Protein Skp2 in Adhesion-Dependent Cell Cycle Progression
por: Carrano, Andrea C., et al.
Publicado: (2001)

SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination
por: Li, Ce, et al.
Publicado: (2019)

Skp2 deficiency restricts the progression and stem cell features of castration-resistant prostate cancer by destabilizing Twist
por: Ruan, Diane, et al.
Publicado: (2017)

Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells
por: Zhou, Huiling, et al.
Publicado: (2023)

Inhibition of Skp2 Sensitizes Chronic Myeloid Leukemia Cells to Imatinib
por: Chen, Xiaowen, et al.
Publicado: (2020)

Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade
por: Mickova, Alena, et al.
Publicado: (2021)

Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression
por: Allain, Eric P., et al.
Publicado: (2020)

Emerging roles of circular RNAs in gastric cancer metastasis and drug resistance
por: Wang, Xiaolin, et al.
Publicado: (2022)

Downregulation of decidual SKP2 is associated with human recurrent miscarriage
por: Lv, Shijian, et al.
Publicado: (2021)

A Skp2 autoinduction loop and restriction point control
por: Yung, Yuval, et al.
Publicado: (2007)

Immunohistochemical expression of Skp2 protein in oral nevi and melanoma
por: Benevenuto-de-Andrade, Bruno A., et al.
Publicado: (2013)

The Impact of SKP2 Gene Expression in Chronic Myeloid Leukemia
por: Hodeib, Hossam, et al.
Publicado: (2022)

Skp2 Expression Is Inhibited by Arsenic Trioxide through the Upregulation of miRNA-330-5p in Pancreatic Cancer Cells
por: Gao, Jiankun, et al.
Publicado: (2019)

Emerging targets in cancer drug resistance
por: Kumar, Shashank, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_76q2ofj0ol9m2fssa6sgj77sdc